Chem. J. Chinese Universities ›› 2019, Vol. 40 ›› Issue (12): 2502.doi: 10.7503/cjcu20190544

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Biological Activity in vitro of Imidazo[4,5-c]quinoline Derivatives

Yanjie LI1,2,Ensi WANG1,Xiaowei SHAO1,Xingmin ZHANG3,Shengxiu NIU1,Lijuan YANG1,Yi WU1,*()   

  1. 1. College of Pharmacy, Jilin University, Changchun 130012, China
    2. College of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun 130117, China
    3. Beijing Foreland Pharma Biological Technology Co., Ltd., Beijing 101111, China
  • Received:2019-10-21 Online:2019-12-04 Published:2019-12-04
  • Contact: Yi WU E-mail:wuyi@jlu.edu.cn
  • Supported by:
    ? Supported by the Fund of Jilin University(China) Hi-Tech(Group) Co., Ltd..

Abstract:

In search of new and efficient PI3K/mTOR inhibitor based on the imidazoquinoline structural framework, 15 novel imidazo[4,5-c] quinoline were synthesized via SNAr reaction of 4-chloroquinoline with aniline, the Traube condensation reaction of aromatic diamine with triphosgene and the Suzuki coupling reaction of bromo-compounds with 3-quinoline boronic acid. The structures of the key intermediates and target compounds were confirmed by 1H NMR, 13C NMR and HRMS. Imidazo[4,5-c] quinolin analogues(8Aa—8Ae, 8Ba—8Be, 8Ca—8Ce) were evaluated for their in vitro activities against PI3Kα/mTOR by ADP-Glo kinase assay and TR-FRET assay, all compounds displayed strong activities.

Key words: Imidazoquinoline, Traube reaction, Suzuki reaction, PI3K/mTOR Dual inhibitor

CLC Number: 

TrendMD: